Metraipolis › archive › dc_2baa13ea389e
Mesothelin biology and the evolving landscape of targeted immunotherapy — Europe PMC PMID:41994562
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41994562
- DOI
- 10.1016/j.omton.2026.201148
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:15:29.319Z
- SHA-256 of the archived text
9abf861ed782b36ebddc7b0989afc6287e32f4db13c2e150d74c373a118b0300- Stable URL of this page
https://metraipolis.com/documento/dc_2baa13ea389e
How to cite
Mesothelin biology and the evolving landscape of targeted immunotherapy — Europe PMC PMID:41994562 — Europe PMC (en), https://europepmc.org/article/MED/41994562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2baa13ea389e (Metraipolis archive dc_2baa13ea389e, sha256 9abf861ed782b36ebddc7b0989afc6287e32f4db13c2e150d74c373a118b0300)
BibTeX
@misc{dc2baa13ea389e,
title = {Mesothelin biology and the evolving landscape of targeted immunotherapy — Europe PMC PMID:41994562},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41994562},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2baa13ea389e; sha256 9abf861ed782b36ebddc7b0989afc6287e32f4db13c2e150d74c373a118b0300},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41994562. Agents can read the archived copy with the MCP tool read_document.